A Premier Centre for Cutting Edge Cancer Research.
A dynamic research institute encompassing basic and translational studies, devoted to understanding the pathogenesis and treatment of cancer
September is Blood Cancer Awareness Month: 5 Questions with A/Prof Takaomi Sanda
CSI Principal Investigator, A/Prof Takaomi Sanda shares with us his journey as a researcher in hematology and oncology, as well as the motivation behind his research work on Blood Cancer.
Read More
Congratulations to Prof. Chng Wee Joo for being the first Asian recipient of the prestigious 2020 Brian G.M Durie Outstanding Achievement Award!
The award was given on August 26, 2020 during the 11th Annual International Myeloma Working Group (IMWG) summit.
Read More
CSI Singapore Clinches Multiple Awards at NCAM 2020 Digital Meeting
The 7th NCIS Annual Research Meeting (NCAM) 2020 recently concluded its first digital meeting, which took place from 22 - 25 July 2020.
Read More
Novel Digital Medicine Platform Offers New Hope for Lymphoma Patients
Researchers from CSI Singapore and NCIS recently harnessed the Quadratic Phenotypic Optimisation Platform (QPOP), an AI-driven digital medicine platform, to revolutionize the treatment for lymphoma.
Read More
(Blood, Jun 2020)
Lysine Acetyltransferase Tip60 Is Required for Hematopoietic Stem Cell Maintenance.
Read More
(Sci Adv, Jun 2020)
Suppression of Adenosine-To-Inosine (A-to-I) RNA Editome by Death Associated Protein 3 (DAP3) Promotes Cancer Progression.
Read More
Giving to CSI
You can help us to shape the next generation of innovative cancer research
